MICHAEL NORDTVEDT

Partner
Corporate

EXPERIENCE:

Michael Nordtvedt is a partner at Wilson Sonsini Goodrich & Rosati, where he focuses on the representation of public and private technology, medical device, and life sciences companies through all stages of their growth, as well as investment banks and venture capital and private equity firms.

Michael specializes in corporate and securities law, including general corporate representation, public offerings, private placements, and mergers and acquisitions. He also has considerable experience in counseling publicly held companies on disclosure matters and complex securities laws issues. Michael frequently represents investment banks in their underwriting transactions and he also has broad transactional experience representing venture capital and private equity firms. Throughout the course of his career he has had responsibility for structuring and negotiating in excess of $40 billion in public and private financing transactions, for both companies and investment banks.

Prior to joining the firm in 2007, Michael practiced in the corporate group at Davis Polk & Wardwell in New York and Menlo Park, California. Michael also served in the United States Navy as an engineering officer aboard USS Lake Champlain (CG57), as executive and weapons officer aboard USS Monsoon (PC4), and at the Pentagon as an action officer responsible for international technology transfer issues.

SELECT CLIENTS:

Companies represented in public offerings, private placements, mergers and acquisitions, and corporate law and governance include:

  • Alpine Immune Sciences
  • Apptio
  • Bardy Diagnostics
  • CorneaGen
  • CTI BioPharma
  • DigiCert
  • Domo
  • Impinj
  • Juno Therapeutics
  • Kodiak Sciences
  • NanoString Technologies
  • Nohla Therapeutics
  • POET
  • Rightside
  • Valent BioSciences
  • Vivint Solar

Investment banks represented in public offerings and private placements include:

  • Barclays
  • BofA Merrill Lynch
  • Citigroup
  • Credit Suisse
  • Deutsche Bank Securities
  • Goldman Sachs
  • Jefferies
  • J.P. Morgan
  • Leerink Partners
  • Morgan Stanley
  • RBC Capital Markets
EDUCATION:
  • J.D., Georgetown University Law Center, 2001
    Magna Cum Laude; Order of the Coif; Editor, The Georgetown Law Journal
  • B.S.F.S., Georgetown University, 1994
    Magna Cum Laude, Phi Beta Kappa
HONORS:
SELECT PUBLICATIONS:
  • Co-author, "Guidance on Emerging Growth Companies," The Lexis Practice Advisor Journal, Spring 2017
SELECT SPEAKING ENGAGEMENTS:
  • "IPO and Liquidity Conference: Preparing for the Capital Markets," PricewaterhouseCoopers, RR Donnelley, Nasdaq, and Goldman Sachs, Seattle, Washington, June 2017
  • "2016 IPO and Liquidity Conference: Preparing for the Capital Markets," PricewaterhouseCoopers, Portland, Oregon, November 2016
  • "2016 IPO and Liquidity Conference: Preparing for the Capital Markets," PricewaterhouseCoopers, RR Donnelley, and Nasdaq, Seattle, Washington, and Vancouver, British Columbia, June 2016
  • "IPO Seminar," NASDAQ OMX, Seattle, Washington, September 2014
  • "Securities Filings 2013: Practical Guidance in a Changing Environment," Practicing Law Institute, New York, New York, September 2013
  • "IPO Seminar," NASDAQ OMX, Seattle, Washington, April 2013
  • "Taking Advantage of the JOBS Act," Law Seminars International, Seattle, Washington, May 2012
  • "Managing the IPO Process in Times of Market Volatility: Legal and Practical Cons," Thomson Reuters webcast (West LegalEdcenter), October 2011
ADMISSIONS:
  • State Bar of California
  • State Bar of New York
  • State Bar of Washington
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Southern District of New York